Haemonetics HAE
NYSE HAE
$101.14 -2.02 (-1.96%)
As of: Sep 10, 2026 · 3:59 PM EDT

Haemonetics (HAE) Revenue Growth (3y) (2012 - 2026)

Analysis

Haemonetics (HAE) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 8.07%
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 18.10%
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 8.20%
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 9.66%
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 14.78%
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 10.83%
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 4.73%
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 14.51%
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 8.05%
10 Haemonetics 4.60 Bn 4.37 Bn 202.80 Mn 2.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 2.92%
Mar 28, 2026 4.40%
Dec 27, 2025 3.55%
Sep 27, 2025 3.24%
Jun 28, 2025 7.12%
Mar 29, 2025 7.65%
Dec 28, 2024 10.30%
Sep 28, 2024 12.93%
Jun 29, 2024 13.73%
Mar 30, 2024 15.12%
Dec 30, 2023 11.84%
Sep 30, 2023 14.95%
Jul 1, 2023 16.76%
Apr 1, 2023 8.48%
Dec 31, 2022 5.64%
Oct 1, 2022 5.61%
Jul 2, 2022 3.12%
Apr 2, 2022 2.06%
Jan 1, 2022 1.65%
Oct 2, 2021 -0.23%